Publicly available datasets reported in this paper are from the GEO databases (GSE13911, GSE27342, and GSE13861) and The Cancer Genome Atlas
Other gastrointestinal effects that may occur on the first day or within the initial week include mild abdominal discomfort, bloating, or changes in bowel habits
Quality assessment and risk of bias The quality of the studies was assessed using appropriate tools based on the study design
GLP-1 Receptor Agonist Compounded Liraglutide Injection Subcutaneous injection prepared as a sterile formulation for weight management support 6 mg/mL 7.5 mL vial Subcutaneous Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist
[17] When asked by The Daily Telegraph , Shavershian denied ever using steroids, and claimed that his physique was the result of hard work in the gym and a strict diet
At the highest dose combination tested, people lost 42% of their total body fat mass in 48 weeks of treatment